University of California, Los Angeles
13 articles about University of California, Los Angeles
UCLA/Luskin Orthopaedic Institute for Children to Host Professional Conference and Family Forum for National Cerebral Palsy Awareness Day on March 25, 2023
Cerebral palsy is the most common childhood physical disability in the United States and throughout the world.
CancerVax Universal Cancer Vaccine Being Developed by UCLA
CancerVAX, Inc. announced that its sponsored research program with the University of California Los Angeles to research and develop a universal cancer vaccine is now fully under way.
Published UCLA and Spectrum Solutions Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers
Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles and Dr. David Wong, UCLA School of Dentistry.
UCLA researchers report gene therapy may correct a rare creatine deficiency disorder that results in intellectual disabilities, issues with speech, involuntary movements and recurrent seizures.
Researchers at the University of California, Los Angeles have identified a neurological mechanism behind memory linking.
Long COVID is loosely defined as COVID-19 symptoms that persist for longer than four weeks from an initial diagnosis. Here’s a look at the latest in long COVID research.
Octant announced an $80 million Series B financing round, a Deep Mutual Scanning (DMS) biopharma partnership with Bristol Myers Squibb and key appointments to its leadership.
Deepcell, a biotechnology company spun out of Stanford University in 2017, focuses on quantifying and understanding morphology – part of the cell’s phenotype.
Qulipta is the first calcitonin gene-related peptide (CGRP) receptor antagonist specifically developed for this indication.
CancerVAX Announces Research Program to Develop Its First Immunotherapy Cancer Treatment
The Company has entered into an agreement with UCLA to develop an immunotherapy breakthrough targeted at treating Ewing sarcoma, a rare but deadly soft tissue and bone cancer that primarily affects children and young adults
Being Overweight May Be Linked to Better Survival from Stroke
It may seem counterintuitive, but having some extra body fat may be linked to an increased chance of surviving a stroke, according to a preliminary study released that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.
Helperby Therapeutics and UCLA to Collaborate on New Fast Track Antibiotic Therapies Aiming to Bring New Sophisticated Combination Therapies to Market in a Much-Reduced Timescale
WHO World Antibiotic Awareness week 2018 [12-18 November]
Merus Announces Formation of a Scientific Advisory Board
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced the formation of a Scientific Advisory Board (SAB), consisting of several world-renowned immuno-oncology and drug development professionals.